Mostra el registre parcial de l'element

dc.contributor.authorMoreno-Chico, Cibeles
dc.contributor.authorGonzález-de Paz, Luis
dc.contributor.authorMonforte-Royo, Cristina
dc.contributor.authorArrighi, Emilia
dc.contributor.authorNavarro-Rubio, M. Dolores
dc.contributor.authorGallart Fernández-Puebla, Alberto
dc.date.accessioned2024-01-18T15:33:45Z
dc.date.available2024-01-18T15:33:45Z
dc.date.issued2017
dc.identifier.citationMoreno-Chico, Cibeles; González-de Paz, Luis; Monforte-Royo, Cristina [et al.]. Adaptation to european spanish and psychometric properties of the patient activation measure 13 in patients with chronic diseases. Family Practice, 2017, 34(5), p. 627-634. Disponible en: <https://academic.oup.com/fampra/article/34/5/627/3093633?login=true>. Fecha de acceso: 18 ene. 2024. DOI: 10.1093/fampra/cmx022ca
dc.identifier.issn1460-2229ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/3909
dc.description.abstractBackground: The 13-item Patient Activation Measure (PAM-13) is an instrument that assesses people’s knowledge, skills and confidence for self-management of their health and health care. Scores on the PAM-13 have been shown to predict adherence to health behaviours, health-related outcomes and health care costs. Objectives: To develop a European Spanish adaptation of the original PAM-13 and to examine its psychometric properties in a sample of chronic patients. Methods: The PAM-13 was forward-backward translated and then completed by chronic patients attending a primary health care centre. Data were analysed with a Rasch model. We assessed the functioning of the rating scale, its reliability, the item goodness-of-fit, differential item functioning (DIF), local dependence, unidimensionality and correlation analysis. Results: A total of 208 patients (80%) completed the questionnaire. Data showed a fit to the Rasch model. More than 50% of patients endorsed all the items. Item rank for the Spanish sample was similar to the original, with few differences. We found significant differences (P < 0.05) in PAM-13 measures according to adherence to prescribed medicines and positive correlations with self-efficacy and physical quality of life.. Conclusions: The European Spanish PAM-13 is a reliable and valid instrument for assessing activation in patients with chronic disease in Spain. We suggest adding new items to the instrument so as to examine patients with higher activation levels in the future. Further studies are needed to evaluate the usefulness of this new Spanish PAM-13 in different settings and populations, as well as to examine the relationship between PAM-13 scores and other health-related outcomes.ca
dc.format.extent7ca
dc.language.isoengca
dc.publisherOxford University Pressca
dc.relation.ispartofFamily Practiceca
dc.relation.ispartofseries34;5
dc.rights© 2024 Oxford University Press
dc.subject.otherMalaltia crònicaca
dc.subject.otherActivació del pacientca
dc.subject.otherPsicometriaca
dc.subject.otherAtenció primària de salutca
dc.subject.otherTraduccióca
dc.subject.otherEspanyaca
dc.subject.otherEnfermedad crónicaca
dc.subject.otherActivación del pacienteca
dc.subject.otherPsicometríaca
dc.subject.otherAtención primaria de saludca
dc.subject.otherTraducciónca
dc.subject.otherEspañaca
dc.subject.otherChronic diseaseca
dc.subject.otherPatient activationca
dc.subject.otherPsychometricsca
dc.subject.otherPrimary health careca
dc.subject.otherTranslationca
dc.subject.otherSpainca
dc.titleAdaptation to european spanish and psychometric properties of the patient activation measure 13 in patients with chronic diseasesca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc61ca
dc.identifier.doihttps://dx.doi.org/10.1093/fampra/cmx022ca


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Comparteix a TwitterComparteix a LinkedinComparteix a FacebookComparteix a TelegramComparteix a WhatsappImprimeix